特发性肺纤维化患者血清TGF—β、IFN—γ水平变化的意义(4)
[12] Majumdar S，Li D，Ansari J，et al.Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systenic sclerosis：a quantitafive study of open lung biopsies[J].Eur Respir J，1999，14(2)：251-257.
[13] Chen E S，Greenlee B M，Wills-Karp M，et al.Affenuation of lung inflammation and fibrosis in interferon-gamma-deticient mice after intratracheal bleomycin[J].Am J Respir Cell Mol Biol，2001，24(5)：545-555.
[14] Tsoutsou P G，Gourgoulianis K I，Petinaki E，et al.Cytokine levels in the sera of patients with idiopathic pulmonary fibrosis[J].Res Med，2006，100(5)：938-945.
[15] Segel M J，Izbicki G，Cohen P Y，et al.Role of interferon gamma in the evolution of murinr bleomycine lung fibrosis[J].Am J Physiol Lung Cell Mol Physiol，2003，285(6)：1255-1262.
[16] Ziesche R，Hofbauer E，Wittmann K，et al.A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis[J].
N Engl J Med，1999，341(17)：1264-1269.
[17]于麗萍，李时悦，林心情，等.肿瘤标志物与特发性肺纤维化严重程度的相关性分析[J].实用医学杂志，2013，29(20)：3333-3335.
[18] Bonella F，Wessendorf T E，Costabel U.Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis[J].Deutsche Medizinische Wochenschrift，2013，138(11)：518-523.
[19] Jaffe H A，Gao Z C，Mori Y，et al.Selective inhibition of collagen gene expression in fibroblasts by an interferon-tranans gene[J].Exp Lung Res，1999，25(3)：199-215.
[20] Maeyama T，Kuwano K，Kawasaki M，et al.Attenuation of bleomycin-induced pneumopathy in mice by monoclonal antibody to interleukin-12[J].Am J Physiol Lung Cell Mol Physiol，2001，280(6)：1128-1137.
(收稿日期：2017-10-16) (本文编辑：董悦), 百拇医药(张晓玲)
[13] Chen E S，Greenlee B M，Wills-Karp M，et al.Affenuation of lung inflammation and fibrosis in interferon-gamma-deticient mice after intratracheal bleomycin[J].Am J Respir Cell Mol Biol，2001，24(5)：545-555.
[14] Tsoutsou P G，Gourgoulianis K I，Petinaki E，et al.Cytokine levels in the sera of patients with idiopathic pulmonary fibrosis[J].Res Med，2006，100(5)：938-945.
[15] Segel M J，Izbicki G，Cohen P Y，et al.Role of interferon gamma in the evolution of murinr bleomycine lung fibrosis[J].Am J Physiol Lung Cell Mol Physiol，2003，285(6)：1255-1262.
[16] Ziesche R，Hofbauer E，Wittmann K，et al.A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis[J].
N Engl J Med，1999，341(17)：1264-1269.
[17]于麗萍，李时悦，林心情，等.肿瘤标志物与特发性肺纤维化严重程度的相关性分析[J].实用医学杂志，2013，29(20)：3333-3335.
[18] Bonella F，Wessendorf T E，Costabel U.Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis[J].Deutsche Medizinische Wochenschrift，2013，138(11)：518-523.
[19] Jaffe H A，Gao Z C，Mori Y，et al.Selective inhibition of collagen gene expression in fibroblasts by an interferon-tranans gene[J].Exp Lung Res，1999，25(3)：199-215.
[20] Maeyama T，Kuwano K，Kawasaki M，et al.Attenuation of bleomycin-induced pneumopathy in mice by monoclonal antibody to interleukin-12[J].Am J Physiol Lung Cell Mol Physiol，2001，280(6)：1128-1137.
(收稿日期：2017-10-16) (本文编辑：董悦), 百拇医药(张晓玲)
参见：首页 > 医疗版 > 疾病专题 > 呼吸内科 > 弥漫性间质性肺病 > 特发性肺纤维化